The Monoclonal Antibody Therapeutics market was valued at USD 263.22 Billion in 2024 and is expected to reach USD 719.81 Billion by 2032, growing at a CAGR of 13.4% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.